-
-
-
-
-
-
-
iBio, Inc. (IBIO) Misses Q3 EPS by 7c
-
-
-
-
-
-
-
iBio, Inc. (IBIO) files for 11.06M share offering by selling stockholders
-
-
-
-
-
-
-
iBio (IBIO) Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment
-
-
-
-
-
-
-
iBio, Inc. (IBIO) Files $150M Mixed Shelf
-
466,185 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

